LRP4 and myasthenia gravis: MG shows altered neuromuscular transmission due to the targeting of acetylcholine receptor (AChR) and muscle receptor-associated proteins, such as muscle-specific tyrosine kinase (MuSK) and low-density lipoprotein receptor-related protein 4 (LRP4) [5].